T1	Participants 362 421	Four hundred sixty-nine assessable advanced cancer patients
T2	Participants 582 781	Eligible patients acknowledged that loss of appetite or weight was a problem and reported the loss of 5 pounds or more during 2 months and/or a daily intake of less than 20 calories/kg of body weight
T3	Participants 1007 1034	dronabinol-treated patients
T4	Participants 912 946	megestrol acetate-treated patients
T5	Participants 1436 1493	egestrol acetate-treated and combination-treated patients
T6	Participants 1665 1699	men who received megestrol acetate
